HIGHLIGHTS
- who: Ziqin Cao and colleagues from the Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, China have published the paper: Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression, in the Journal: BioMed Research International of 11/06/2022
- what: The study is aimed at comparing the clinical efficacy tolerability and safety of different biological agents including novel IL-6 inhibitor (IL6i) IL-23 inhibitor (IL23i) and IL-17 A/F dual variable domain inhibitor (IL17AFi) in AS. The study investigated a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.